Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_assertion type Assertion NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_head.
- NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_assertion description "[Allorestricted TCRs with specificity for naturally presented FMNL1-derived epitopes may represent promising reagents for the development of adoptive therapies in lymphoma and other malignant diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_provenance.
- NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_assertion evidence source_evidence_literature NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_provenance.
- NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_assertion SIO_000772 17626842 NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_provenance.
- NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_assertion wasDerivedFrom befree-20140225 NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_provenance.
- NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_assertion wasGeneratedBy ECO_0000203 NP847532.RA8BL0eFI8HSWB5wSI-s4Akf_t1yqfYu4Ol8dJwE_66DI130_provenance.